• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Systematic evidence-based review: The application of noninvasive prenatal screening using cell-free DNA in general-risk pregnancies.

作者信息

Rose Nancy C, Barrie Elizabeth S, Malinowski Jennifer, Jenkins Gabrielle P, McClain Monica R, LaGrave Danielle, Leung Marco L

出版信息

Genet Med. 2022 Sep;24(9):1992. doi: 10.1016/j.gim.2022.07.002.

DOI:10.1016/j.gim.2022.07.002
PMID:36063164
Abstract
摘要

相似文献

1
Systematic evidence-based review: The application of noninvasive prenatal screening using cell-free DNA in general-risk pregnancies.基于循证医学的系统评价：游离DNA无创产前筛查在一般风险妊娠中的应用
Genet Med. 2022 Sep;24(9):1992. doi: 10.1016/j.gim.2022.07.002.
2
Systematic evidence-based review: The application of noninvasive prenatal screening using cell-free DNA in general-risk pregnancies.系统循证评价：应用游离胎儿 DNA 进行一般风险孕妇的产前筛查。
Genet Med. 2022 Jul;24(7):1379-1391. doi: 10.1016/j.gim.2022.03.019. Epub 2022 May 24.
3
Residual risk for clinically significant copy number variants in low-risk pregnancies, following exclusion of noninvasive prenatal screening-detectable findings.在排除了无创产前筛查可检测到的结果后，低风险妊娠中临床显著拷贝数变异的残留风险。
Am J Obstet Gynecol. 2022 Apr;226(4):562.e1-562.e8. doi: 10.1016/j.ajog.2021.11.016. Epub 2021 Nov 8.
4
Noninvasive prenatal screening in twin pregnancies with cell-free DNA using the IONA test: a prospective multicenter study.应用 IONA 测试的双胎妊娠游离胎儿 DNA 非侵入性产前筛查：一项前瞻性多中心研究。
Am J Obstet Gynecol. 2021 Jul;225(1):79.e1-79.e13. doi: 10.1016/j.ajog.2021.01.005. Epub 2021 Jan 15.
5
The yield of chromosomal microarray in pregnancies with congenital cardiac defects and normal noninvasive prenatal screening.先天性心脏缺陷且无创性产前筛查正常的妊娠患者中进行染色体微阵列分析的效果。
Am J Obstet Gynecol. 2021 Sep;225(3):333.e1-333.e14. doi: 10.1016/j.ajog.2021.05.022. Epub 2021 May 27.
6
Sequencing shorter cfDNA fragments improves the fetal DNA fraction in noninvasive prenatal testing.短 cfDNA 片段测序可提高无创产前检测中胎儿 DNA 比例。
Am J Obstet Gynecol. 2019 Oct;221(4):345.e1-345.e11. doi: 10.1016/j.ajog.2019.05.023. Epub 2019 May 21.
7
Chromosomal Microarray Analysis Compared With Noninvasive Prenatal Testing in Pregnancies With Abnormal Maternal Serum Screening.染色体微阵列分析与异常母体血清筛查妊娠中的非侵入性产前检测比较。
Obstet Gynecol. 2022 May 1;139(5):877-887. doi: 10.1097/AOG.0000000000004758. Epub 2022 Apr 5.
8
Application of Non-Invasive Prenatal Tests in Serological Preclinical Screening for Women with Critical-Risk and Low-Risk Pregnancies but Abnormal Multiple of the Median Values.无创产前检测在临界风险和低风险妊娠但中位数倍数异常的女性血清学临床前筛查中的应用
Clin Lab. 2020 Jul 1;66(7). doi: 10.7754/Clin.Lab.2020.191212.
9
Have we done our last amniocentesis? Updates on cell-free DNA for Down syndrome screening.我们是否已进行了最后一次羊膜穿刺术？唐氏综合征筛查中游离DNA检测的最新进展。
Pediatr Radiol. 2018 Apr;48(4):461-470. doi: 10.1007/s00247-017-3958-y. Epub 2018 Mar 17.
10
Use of cell-free fetal DNA in maternal plasma for noninvasive prenatal screening.游离胎儿DNA在母血中用于无创产前筛查
Clin Perinatol. 2014 Dec;41(4):957-66. doi: 10.1016/j.clp.2014.08.013. Epub 2014 Oct 1.

引用本文的文献

1
Noninvasive prenatal testing: an overview.无创产前检测：综述。
Aust Prescr. 2025 Apr;48(2):47-53. doi: 10.18773/austprescr.2025.019.
2
Tell me y: anticipation of sex discrepancies in cell-free DNA testing due to maternal genetic abnormalities: a case report.因母体基因异常导致游离DNA检测中性别差异预期：一例报告 告诉我y
Front Genet. 2025 Jan 20;15:1502287. doi: 10.3389/fgene.2024.1502287. eCollection 2024.
3
'Screening should not be based on ability to pay': Australian healthcare providers' and consumers' perspectives on public funding for non-invasive prenatal testing.
“筛查不应基于支付能力”：澳大利亚医疗服务提供者和消费者对非侵入性产前检测公共资金的看法。
Aust N Z J Obstet Gynaecol. 2025 Jun;65(3):409-419. doi: 10.1111/ajo.13915. Epub 2025 Jan 13.
4
The Next Frontier in Neurology Is In Utero.神经学的下一个前沿领域在子宫内。
JAMA Neurol. 2023 Oct 1;80(10):1015-1016. doi: 10.1001/jamaneurol.2023.2965.
5
Challenges in the clinical understanding of genetic testing in birth defects and pediatric diseases.出生缺陷和儿科疾病基因检测临床理解方面的挑战。
Transl Pediatr. 2023 May 30;12(5):1028-1040. doi: 10.21037/tp-23-54. Epub 2023 May 4.
6
Positive cfDNA screening results for 22q11.2 deletion syndrome-Clinical and laboratory considerations.22q11.2缺失综合征的循环游离DNA（cfDNA）筛查阳性结果——临床及实验室考量
Front Genet. 2023 Mar 10;14:1146669. doi: 10.3389/fgene.2023.1146669. eCollection 2023.
7
Prenatal Screening and Diagnostic Considerations for 22q11.2 Microdeletions.22q11.2 微缺失的产前筛查和诊断注意事项。
Genes (Basel). 2023 Jan 6;14(1):160. doi: 10.3390/genes14010160.